Sundeep Khosla, MD discusses Amgen’s Denosumab

August 11, 2009- Sundeep Khosla of the Mayo Clinic who authored the NEJM editorial on Amgen’s denosumab discusses the drug and safety issues.

This entry was posted in - Biotech, - Pharma, Mayo Clinic. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *